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ABSTRACT
Objectives: To assess the stage at cancer diagnosis
and survival after cancer diagnosis among people
served by secondary mental health services, compared
with other local people.
Setting: Using the anonymised linkage between a
regional monopoly secondary mental health service
provider in southeast London of four London
boroughs, Croydon, Lambeth, Lewisham and
Southwark, and a population-based cancer register,
a historical cohort study was constructed.
Participants: A total of 28 477 cancer cases aged 15+
years with stage of cancer recorded at diagnosis were
identified. Among these, 2206 participants had been
previously assessed or treated in secondary mental
healthcare before their cancer diagnosis and 125 for
severe mental illness (schizophrenia, schizoaffective or
bipolar disorders).
Primary and secondary outcome measures: Stage
when cancer was diagnosed and all-cause mortality
after cancer diagnosis among cancer cases registered in
the geographical area of southeast London.
Results: Comparisons between people with and
without specific psychiatric diagnosis in the same
residence area for risks of advanced stage of cancer at
diagnosis and general survival after cancer diagnosed
were analysed using logistic and Cox models. No
associations were found between specific mental
disorder diagnoses and beyond local spread of cancer
at presentation. However, people with severe mental
disorders, depression, dementia and substance use
disorders had significantly worse survival after cancer
diagnosis, independent of cancer stage at diagnosis and
other potential confounders.
Conclusions: Previous findings of associations
between mental disorders and cancer mortality are
more likely to be accounted for by differences in
survival after cancer diagnosis rather than by delayed
diagnosis.
INTRODUCTION
Numerous studies have indicated a higher
risk of all-cause mortality and shorter life
expectancy for people with severe mental
illness (SMI), including schizophrenia,
bipolar disorder, schizoaffective disorder
and, sometimes, depressive disorders.1–8 The
proﬁle of causes of death among people with
SMI is not substantially different from that in
general population, although some speciﬁc
patterns of death have been suggested, differ-
ing by sex, age group and mental disorder
diagnosis.3 5–7 9–13 In recent decades, cardio-
vascular disease, stroke, respiratory diseases,
suicide and cancer have remained the
leading causes.3 5–7 9–13
A recent population-based study revealed
that men with psychiatric admissions before
cancer registration had a signiﬁcantly worse
survival, especially for those with depressive
disorders, neurotic and adjustment disorders,
and alcohol-related or other substance use
disorders.14 Results from three population-
based cohort studies showed signiﬁcantly
increased cancer mortality among people
with schizophrenia for both genders,5 9 15
but some other studies reported that it
occurred in men7 13 16 17 or women only.18
Strengths and limitations of this study
▪ Longitudinal study design with a data linkage
between two case register systems in London, UK.
▪ Mortality information was retrieved from the
national registry of death certificates in the UK.
▪ The completeness rate of cancer stage was
about 65%, which is within the range reported
by other cancer registries in England and did not
differ for most of the mental disorder groups of
research interest compared with the remaining
population.
▪ Lack of lifestyle factors (smoking, drinking, diet,
obesity and physical activities) for confounding
control in survival analysis.
▪ Small numbers of cancer cases with some spe-
cific mental disorders did not permit restricting
the sample for sensitivity analyses. Also, size of
the linked sample also did not allow further ana-
lyses of individual cancer diagnoses.
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However, other studies found no association with cancer
mortality for SMI as a whole or schizophrenia speciﬁc-
ally7 13 16 17 and even a reduced risk was reported in
one study.6 Depression has also been found to be asso-
ciated with an increase in cancer mortality.18 Studies of
the incidence of cancer in people with SMI have princi-
pally focused on schizophrenia with varying results,
including reduced total cancer incidence,19–25 no differ-
ence26–29 or increased risk.30 A meta-analysis pooling
eight studies concluded no association between schizo-
phrenia and incidence of cancer.27 A history of depres-
sion or alcohol-related or substance use disorders has
been associated with increased cancer,31 but inconsistent
ﬁndings have been found for bipolar disorder,32 33
dementia15 18 34 and null for schizoaffective disorder.29
Evidence on the role of mental disease as a comorbidity
factor in cancer is, therefore, still far from conclusive,
but tends to indicate cancer incidence that is either
reduced or not different, and cancer mortality that is
increased.32 33
Thinking of how to solve the puzzle shown on conﬂict-
ing research results and effects of mental disorders to
cancer prognosis, there are two key research questions
to be answered. First, to what extent might the reduced
recognition of early cancer symptoms in people with
mental disorders inﬂuence the stage of cancer at diag-
nosis?33 35–37 And, second, what is the role of mental dis-
orders on mortality after cancer diagnosis if the issue of
later presentation of cancer could be ruled out? Then,
an inﬂuence of mental disorders on cancer mortality in
the absence of a clear effect on underlying risk could be
explained by differences in treatment access, response
and adherence, as previously raised by Kisely et al.15 38
Utilising a data linkage between a large secondary
mental healthcare case register in southeast London
and the regional cancer registry, we sought to investigate
associations between mental disorder and disease stage
at cancer diagnosis and subsequent survival.
MATERIALS AND METHODS
The South London and Maudsley NHS Foundation Trust
Biomedical Research Centre Case Register
The South London and Maudsley NHS Foundation
Trust (SLAM) Biomedical Research Centre (BRC) Case
Register was used to provide data on mental disorders
for the current study. SLAM is the near-monopoly pro-
vider of comprehensive secondary mental health services
for a geographic catchment consisting of four London
boroughs (Southwark, Lambeth, Lewisham and
Croydon) with approximately 1.23 million residents.
Clients’ records for all the services provided by SLAM
were electronised in 2006. In 2008, the Clinical Record
Interactive Search (CRIS) system was developed as a plat-
form for investigators to search and access full but anon-
ymised clinical data from the fully electronic health
records system in SLAM for research purposes. All
people receiving SLAM care for psychiatric assessments
and/or treatment were included in the database. The
demographic characteristics and clinical proﬁles of the
Case Register population have been fully described
elsewhere.39
Thames Cancer Registry
At the time of the study, Thames Cancer Registry (TCR)
was the largest of eight population-based cancer regis-
tries in England, covering a population of 12 million
residents in London, Kent, Surry and Sussex.
Registration was initiated by pathology reports and clin-
ical records from hospitals and information on death
certiﬁcates were received from the National Health
Service (NHS) Central Register through the Ofﬁce of
National Statistics in 1999. When cancer is recorded as
the main or contributing cause of death in Part 1
section, the certiﬁcate is routinely sent to the regional
cancer registry. Further information on demographic,
clinical details and treatments received within the ﬁrst
6 months after cancer diagnosis was retrieved from hos-
pitals or hospital databases by trained data collection
ofﬁcers. A central regional database was maintained with
data added continuously and robust data quality con-
trols. To avoid double counting, information about new
tumours was cross-checked against existing registered
cases. Cancer registration and cancer surveillance take
place in English registries under provisions of Section
251 of the Health and Social Care Act and this permis-
sion is reviewed annually. The TCR was assessed to be
more than 95% complete in 2001–2007, and considered
as of sufﬁcient quality for cancer outcome analyses.40 41
Anonymised process of data linkage
Data from CRIS and TCR for residents in the SLAM geo-
graphic catchment were linked using an anonymisation
process by the Health Research Support Service (HRSS)
Pilot Programme which was operated by the Department
of Health as part of the NHS Research Capability
Programme in the UK. Memoranda of Understanding
were signed between SLAM and TCR through HRSS,
which in turn designed and created an infrastructure to
provide a safe and conﬁdential platform for health
research. With HRSS as the ‘trusted third party’, the
linkage was performed using a series of identiﬁers
including the NHS number, and was then irreversibly
deidentiﬁed, replacing the NHS number with an
encrypted HRSS identiﬁcation (HRSS id). The initial
sample selected for analysis comprised individuals on
the TCR dataset within SLAM coverage area. Thus, a
retrospective cohort study of people under the care of
secondary mental health services could be performed.
Covariates included
Mental disorder diagnoses were identiﬁed from two
sources within CRIS: (1) a primary psychiatric diagnosis
(Axis 1a) categorised by International Classiﬁcation of
Diseases (ICD)-10 code (a structured ﬁeld, compulsory
for completion by services, with a speciﬁc date in the
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electronic clinical records system) and (2) a supplemen-
tary natural language processing application developed
using General Architecture for Text Engineering
(GATE) software which extracts text strings relating to a
diagnosis statement in correspondence ﬁelds. The ﬁrst
diagnoses from either one or both sources were then
categorised into the following groupings (ICD codes):
dementia (F00–03), substance use disorders (F10–19),
schizophrenia (F20), schizoaffective disorder (F25),
bipolar disorder (F31), depressive disorders (F32–33),
anxiety disorders (F40–42) and personality disorders
(F60–61). SMI was deﬁned as a diagnosis of schizophre-
nia (F20), schizoaffective disorder (F25) or bipolar dis-
order (F31). In the TCR data, tumour stage at
presentation of cancer was routinely extracted from an
individual’s medical records and categorised as follows:
‘local’ (stage 1), ‘extension beyond the organ of origin’
(stage 2), ‘regional lymph node involvement’ (stage 3)
and ‘metastasis’ (stage 4). Cases without sufﬁcient infor-
mation about disease stage were classiﬁed as ‘not
known’. Date of cancer diagnosis, date of birth, sex, type
of cancer, primary care trust (geographic area) and
ethnic group were also routinely collected in TCR and
were used as covariates. In addition, the income domain
of the index of multiple deprivations in 2007 was
derived on the basis of the residential postcode.42
Statistical analysis
All the cancer cases diagnosed in the period from 1999
to 2008 in residents of the catchment area of four
London boroughs under SLAM service coverage were
included in the current analyses. Through the linkage
performed by HRSS, any cancer detected after a contact
with SLAM was marked. If multiple tumours were regis-
tered in one person, only the ﬁrst cancer onset was con-
sidered. Their primary psychiatric diagnosis given in
SLAM services before the cancer was identiﬁed (if any)
as the major exposure of interest in the current analyses.
Stage of disease at cancer diagnosis was categorised into
two groups: (1) early stage with no spread or only local
extension beyond the organ of origin (localised stage)
and (2) late stages with regional lymph node involve-
ment or metastasis (advanced stage). This was treated as
a binary dependent variable and was modelled against
mental disorder diagnoses by logistic regressions. Cox
regression models were then assembled to estimate the
associations between mental disorder and survival after
cancer diagnosis. The duration of follow-up was deﬁned
as the period from cancer diagnosis to the date of death
(any cause) or the end of the follow-up period (12 June
2010), provided by TCR. Age at cancer diagnosis,
gender, type of cancer, year of cancer diagnosis, primary
care trust (geographic area), ethnic groups, deprivation
score for income and stage at cancer diagnosis were
treated as potential confounders, where appropriate.
Area-level deprivation score for income was classiﬁed
into quintiles, with the ﬁrst quintile representing the
most afﬂuent areas and applied as the reference group
in modelling. Stata/IC V.12.1 software for Windows
(Stata Corporation, 2011) was used for all the analyses.
RESULTS
The study sample
A total of 43 746 cancer cases were identiﬁed from TCR
records. Among them, 15 166 participants (34.7%) had
no information about their stage of cancer at diagnosis.
No signiﬁcant associations were found between psychi-
atric diagnosis and missing cancer stage data apart from
a higher proportion of missing data in people with
dementia (46.8%) compared with the remainder (35%).
After the exclusion of people without conﬁrmed cancer
stage information and those younger than 15 years at
cancer diagnosis (n=101), with missing date of birth
(n=1) or date of cancer diagnosis (n=1), 28 477cases
(65.1%) remained and were included in our analyses.
Among them, 55.3% were women. Up to the end of
2008, a total of 2206 of these cancer cases had received
any SLAM service (ie, were present on the CRIS data-
base), and 125 of these had received an SMI diagnosis
prior to their cancer diagnosis.
Factors associated with extent of disease
at cancer diagnosis
Of the analysed sample of cancer cases, 64.2%
(n=18 290) were diagnosed with localised stage of
disease. Descriptive characteristics of the sample by stage
at cancer diagnosis are presented in table 1. Participants
with advanced stage of cancer at diagnosis were older
and more likely to be men (both p values <0.001), and
there was signiﬁcant variation by cancer type, year of
diagnosis, primary care trust and ethnic group (all
p values <0.001), although no clear linear trend for
socioeconomic deprivation was evident (details not
shown).
Mental disorder and stage at cancer diagnosis
Associations between preceding mental disorders and
stage at cancer diagnosis are summarised in table 2. In
summary, ﬁndings were null and there was no evidence
of an association with any diagnostic group after adjust-
ment for age, gender, type of cancer, year of cancer
diagnosis, primary care trust, ethnicity and deprivation
score for income.
Mental disorder and survival after cancer diagnosis
Associations between mental disorders and survival after
cancer diagnosis are summarised in table 3. SMI as a
whole (and schizophrenia and schizoaffective disorder
individually), depression, dementia and substance use
disorders were associated with worse survival after
cancer diagnosis in fully adjusted models, with a rela-
tively little attenuation following adjustment for stage at
cancer diagnosis.
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DISCUSSION
Main findings
This linkage between a population-based cancer register
and a near-monopoly secondary mental health service
provider with a geographic catchment of approximately
1.23 million residents provided a sufﬁciently large
sample for this investigation. The key ﬁndings were that
people who had been diagnosed with speciﬁc mental
disorders in the secondary mental health service were
not more likely to have cancer with advanced stage at
diagnosis, but that many of the mental disorder groups
had worse subsequent survival. This latter ﬁnding was
signiﬁcant for SMI as a whole, and for schizophrenia
and schizoaffective disorder individually, as well as for
those with diagnoses of depression, dementia and sub-
stance use disorders prior to the cancer diagnosis. The
stage of cancer at diagnosis in people with mental disor-
ders did not explain their worse subsequent survival.
Advantages and limitations
The study described beneﬁted from the large size of the
two data sources. The linkage allowed the longitudinal
observation of a substantial number of cases with mental
disorder diagnoses who had subsequently developed
cancer, and comparison group of the remaining people
with cancer diagnoses from the same geographic catch-
ment area. Ascertainment of vital status and deaths was
achieved by linkage to death certiﬁcates provided elec-
tronically from the Ofﬁce for National Statistics.
Limitations include a fairly large proportion with
missing data on cancer stage (34.7%). This complete-
ness level is within the range reported by other English
registries and represents the data available to the regis-
tration process. These levels have been improving with
the receipt of electronic pathology data from hospitals.
Importantly, the proportions with missing stage data did
not differ for most of the mental disorder groups of
primary interest compared with the remaining popula-
tion (the only exception being dementia), and principal
ﬁndings are therefore unlikely to have been biased by
availability of stage information. The other issue was the
lack of lifestyle factors for smoking, drinking, diet,
obesity and physical activities in our dataset, which made
further confounding control inapplicable. Another limi-
tation was that some of the required data on mental dis-
orders were drawn from years when there was less than
Table 1 Descriptive statistics of patients with cancer in southeast London by stage at cancer presentation from 1999 to 2008
Number (%)/mean±SD
All cases
(N=43 454)*
Participants with stage at cancer diagnosis (N=28 477)
Variables
Localised stage
(N=18 290)
Advanced stage
(N=10 187) p Value†
Age at cancer diagnosis (years) 63.31±17.96 60.38±19.15 66.80±14.29 <0.01‡
Gender <0.01‡
Female 23 242 (53.49) 10 257 (56.08) 5490 (53.89)
Male 20 212 (46.51) 8033 (43.92) 4697 (46.11)
Type of cancer <0.01‡
Lung 5286 (12.16) 1724 (9.43) 2068 (20.30)
Bladder 1170 (2.69) 636 (3.48) 111 (1.09)
Breast 5943 (13.68) 2592 (14.17) 1833 (17.99)
Skin 2189 (5.04) 1548 (8.46) 93 (0.91)
Prostate 4975 (11.45) 2657 (14.53) 634 (6.22)
Corpus uteri 804 (1.85) 485 (2.65) 121 (1.19)
Colorectal 3979 (9.16) 1441 (7.88) 1531 (15.03)
Others 19 108 (43.97) 7207 (39.40) 3796 (37.26)
Ethnicity <0.01‡
White 26 055 (59.96) 10 766 (58.86) 6797 (66.72)
Black 5080 (11.69) 2293 (12.54) 1293 (12.69)
East Asian 541 (1.24) 222 (1.21) 135 (1.33)
South Asian 804 (1.85) 258 (1.41) 173 (1.70)
Others/unknown/mixed 10 974 (25.25) 4751 (25.98) 1789 (17.56)
Deprivation score (income) <0.01‡
1st quintile 2465 (5.67) 709 (3.88) 417 (4.09)
2nd quintile 3308 (7.61) 1098 (6.00) 629 (6.17)
3rd quintile 6520 (15.00) 2844 (15.55) 1355 (13.30)
4th quintile 14 114 (32.48) 6130 (33.52) 3308 (32.47)
5th quintile 17 047 (39.23) 7509 (41.06) 4478 (43.96)
*Participants with demographic information.
†Independent t tests for continuous variables and χ2 tests for categorical variables.
‡Statistical significance.
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full information, since electronic records became com-
prehensive across all SLAM services during 2006;
however, the numbers of cases did not permit restricting
the sample any further for sensitivity analyses. The size
of the linked sample also did not permit analyses of indi-
vidual cancer diagnoses. Besides, the signiﬁcant ﬁnding
of schizoaffective disorder for survival after cancer diag-
nosis in table 3 was based on ﬁve cases only.
Comparisons with related studies
In the relatively scarce literature about potentially
delayed cancer diagnoses among people with mental dis-
orders, the most recent published study reported a sig-
niﬁcantly higher proportion of metastasis at cancer
presentation for psychiatric patients compared with
general population (7.1% vs 6.1%) in Western Australia,
especially for the cancer of breast and lung.15 A US
study, linking Surveillance, Epidemiology and End
Results data to Medicare, found that people without
mental disorder were slightly more likely to have an
earlier detection of colon cancer than people who had
any mental disorder (53.3% vs 49.7%), although it was
partially contributed by higher proportion with
unknown stage when colon cancer was diagnosed (6.2%
vs 14.6%). The frequency of diagnosis at autopsy for
colon cancer among people without mental disorder
was also signiﬁcantly lower than cases (1.1% vs 4.4%).35
However, these two studies did not adjust for potential
confounders in their analyses, especially for type of
cancer.15 35 Another study focusing on breast cancer
with confounders adjusted found that a history of major
depression was associated with a delayed diagnosis of
breast cancer representing an almost 10-fold increased
risk, but the opposite direction of association was found
for phobia.43 Although we should have sufﬁcient statis-
tical power to identify the differences, our null ﬁndings
for people undergoing assessment and treatment in sec-
ondary mental health services made the issue about
delayed diagnosis of cancer among people with mental
illness still inconclusive. Although potential explanation
Table 2 Associations between previous diagnosis received in secondary mental healthcare and stage at cancer diagnosis
(N=28 477)
Variables
Cancer stage at diagnosis
N (%) Unadjusted OR for
advanced cancer
stage
(95% CI)
Age- and gender-
adjusted OR for
advanced cancer stage
(95% CI)
Fully adjusted OR for
advanced cancer
stage*
(95% CI)
Localised
stage
(N=18 290)
Advanced
stage
(N=10 187)
SMI†
No 18 208 (64.22) 10 144 (35.78) Ref Ref Ref
Yes 82 (65.60) 43 (34.40) 0.94 (0.65 to 1.36) 1.01 (0.70 to 1.47) 0.94 (0.64 to 1.39)
Schizophrenia
No 18 233 (64.24) 10 151 (35.76) Ref Ref Ref
Yes 57 (61.29) 36 (38.71) 1.13 (0.75 to 1.72) 1.23 (0.81 to 1.88) 1.10 (0.71 to 1.71)
Bipolar disorder
No 18 266 (64.21) 10 180 (35.79) Ref Ref Ref
Yes 24 (77.42) 7 (22.58) 0.52 (0.22 to 1.22) 0.55 (0.24 to 1.30) 0.60 (0.25 to 1.42)
Schizoaffective disorder
No 18 286 (64.22) 10 186 (357.8) Ref Ref Ref
Yes 4 (80.0) 1 (20.0) 0.45 (0.05 to 4.02) 0.47 (0.05 to 4.38) 0.47 (0.04 to 4.95)
Depression
No 18 184 (64.22) 10 129 (35.78) Ref Ref Ref
Yes 106 (64.63) 58 (36.37) 0.98 (0.71 to 1.35) 0.91 (0.66 to 1.26) 0.90 (0.64 to 1.27)
Dementia
No 18 229 (64.26) 10 137 (35.74) Ref Ref Ref
Yes 61 (54.95) 50 (45.05) 1.47 (1.01 to 2.14)‡ 1.00 (0.68 to 1.46) 1.23 (0.82 to 1.85)
Substance use disorders
No 18 260 (64.23) 10 171 (35.77) Ref Ref Ref
Yes 30 (65.22) 16 (34.78) 0.96 (0.52 to 1.76) 1.01 (0.55 to 1.87) 0.99 (0.52 to 1.89)
Anxiety disorders
No 18 263 (64.22) 10 173 (35.78) Ref Ref Ref
Yes 27 (65.85) 14 (34.14) 0.93 (0.49 to 1.78) 0.98 (0.51 to 1.89) 1.15 (0.58 to 2.28)
Personality disorders
No 18 282 (64.24) 10 179 (35.76) Ref Ref Ref
Yes 8 (50.00) 8 (50.00) 1.80 (0.67 to 4.79) 2.15 (0.80 to 5.76) 1.78 (0.65 to 4.88)
*Adjust for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity and deprivation score for income.
†SMI: schizophrenia, bipolar disorder or schizoaffective disorder.
‡Statistical significance.
SMI, severe mental illness.
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about speciﬁc psychological characteristics of disposi-
tional insensitivity to threat (if the relation really exists)
was found to be associated with delayed help seeking for
symptoms of rectal cancer,36 further in-depth investiga-
tions on the effect of mental disorders to physical
healthcare utilisations are needed.
On the issue of survival for people with mental disor-
ders after cancer diagnosis, a previous study of a
population-based male Swedish cohort with psychiatric
admissions before cancer diagnosis by registration found
signiﬁcantly worse survival, especially for those who had
had depressive disorders, neurotic and adjustment disor-
ders, and alcohol-related or other substance use disor-
ders.14 With a similar study design, Kisely et al38
identiﬁed a signiﬁcantly elevated risk of cancer mortality
for people with psychiatric disorder in Canada.
Advanced analyses exploring the reasons for elevated all-
cause mortality following cancer diagnosis were also
reported for people with known mental disorders in
Western Australia, ﬁnding a reduced likelihood of
surgery after diagnosis of colorectal, breast and cervical
cancers in people with mental disorders and less radio-
therapy or chemotherapy receipt.15 The US linkage
between Surveillance, Epidemiology and End Results
data and Medicare found that receipt of colon cancer
treatment (any treatment at all stages or chemotherapy
at stage 3 only) was signiﬁcantly lower for people with
pre-existing any mental disorder, mood disorder, psychi-
atric disorder and dementia.35 Our study provided add-
itional support to the ﬁnding that, although the stage of
diagnosis for cancer of people with mental illness was
not more advanced, these people were still at higher risk
of death compared with their counterparts without
mental illness. The underlying reasons might differ by
medical care system in countries. Further details about
the treatment trajectories after cancer diagnosis for
people with mental disorder are needed for advanced
studies.
Implications and direction for future studies
The wider question about cancer risk and outcome in
people with mental disorders has received considerable
Table 3 Crude and adjusted relative risks for the effect of pre-existing mental disorders on general mortality among patients
with cancer in southeast London by Cox models (N=43 449)
Variables
HR (95% CI)
Age- and gender-adjusted Model 1* Model 2†
SMI‡
No Ref Ref Ref
Yes 1.53 (1.27 to 1.85)§ 1.71 (1.44 to 2.06)§ 1.74 (1.44 to 2.10)§
Schizophrenia
No Ref Ref Ref
Yes 1.71 (1.38 to 2.11)§ 1.91 (1.55 to 2.37)§ 1.90 (1.54 to 2.36)§
Bipolar disorder
No Ref Ref Ref
Yes 1.01 (0.66 to 1.55) 1.13 (0.74 to 1.73) 1.20 (0.78 to 1.85)
Schizoaffective disorder
No Ref Ref Ref
Yes 3.22 (1.45 to 7.17)§ 2.69 (1.21 to 5.98)§ 2.33 (1.05 to 5.20)§
Depression
No Ref Ref Ref
Yes 1.22 (1.04 to 1.44)§ 1.27 (1.07 to 1.49)§ 1.30 (1.11 to 1.54)§
Dementia
No Ref Ref Ref
Yes 1.36 (1.17 to 1.58)§ 1.65 (1.42 to 1.92)§ 1.66 (1.43 to 1.94)§
Substance use disorders
No Ref Ref Ref
Yes 1.24 (0.89 to 1.72) 1.41 (1.02 to 1.96)§ 1.42 (1.02 to 1.97)§
Anxiety disorders
No Ref Ref Ref
Yes 0.74 (0.50 to 1.10) 0.86 (0.58 to 1.30) 0.73 (0.49 to 1.10)
Personality disorders
No Ref Ref Ref
Yes 1.65 (0.94 to 2.91) 1.58 (0.90 to 2.79) 1.50 (0.85 to 2.64)
*Model 1: adjusted for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity and deprivation score for income.
†Model 2: adjusted for age, gender, type of cancer, year of cancer diagnosis, primary care trust, ethnicity, deprivation score for income and
stage at cancer diagnosis.
‡SMI: schizophrenia, bipolar disorder or schizoaffective disorder.
§Statistical significance.
SMI, severe mental illness.
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attention over the years, although studies have princi-
pally investigated overall cancer-related mortality or
cancer incidence. While ﬁndings about cancer screening
uptake rates among people with SMI were inconsistent
across and within countries,44 one possible reason for
reasonably consistent raised cancer-related mortality in
people with mental disorders but inconsistent evidence
for raised cancer incidence is that the mortality is
explained by delays in presentation rather than
increased risk. However, we found no evidence that
prior mental disorder was associated with more
advanced stage of cancer at diagnosis, a measure of
delay in presentation, which might be because that, in
the UK, since 2003, general practitioners have been
incentivised under the guide of Quality and Outcomes
Framework45 to offer regular physical health reviews to
people with long-term mental health problems, includ-
ing preventative cancer screening appropriate to age
and gender since 2006.
Instead, consistent with other ﬁndings,14 15 35 38 we
found an association with worse survival after cancer
diagnosis that was not explained by stage at presentation.
This suggests that effects of mental disorder on cancer
mortality primarily exert themselves after the diagnosis.
Causal pathways might include reduced access to
medical treatment and care, differing decisions about or
tolerance of intensive regimes, and the inﬂuence of
other health problems or drug effects on survival. Also,
there might be differences between cancers on the
impact to survival for early diagnosis, but there were
insufﬁcient data to analyse such differences among types
of cancer. Clearly, the components of such disadvantage
require further evaluation. A greater understanding is
needed on the levels of utilisation of healthcare services
and potential barriers to this among people with mental
illness, including the extent to which this is present
across individual cancer diagnoses and to which it is
accounted for by the speciﬁc symptoms of the mental
disorders themselves, by accompanying social disadvan-
tage, or potentially by stigma. Also worthy of further
evaluation is the potential impact that mental healthcare
could have on improving physical health and other
indirect inﬂuences of mental disorders on adverse
health outcomes.
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